Research > ETFs > ETF / ETP Commentary > 

T. Rowe Price’s Love Discusses ETFs Hitting 3-Year Mark

The ETF three-year milestone is more than just an opportunity for firms to tout their funds or celebrate years of work. That marker has material consequences for current and future investors in a fund, opening up those strategies to new flows. VettaFi sat down with T. Rowe Price lead portfolio manager Jodi Love to discuss that three-year milestone for four ETFs she manages.Key Takeaways: Four major active ETFs at T. Rowe Price hit their important three-year milestones last month. All four share a manager in Jodi Love, who spoke about the changing use cases for those funds and their continued growth. The longevity of the ETFs speaks to the way in which fundamentally driven, active ETFs can appeal. T. Rowe Price Unlocks New OpportunitiesThat quad includes TGRT, TVAL, TMSL, and TOUS, which all launched back in June 2023. The T. Rowe Price Growth ETF (TGRT B+), T. Rowe Price Value ETF (TVAL B+), the T. Rowe Price Small-Mid Cap ETF (TMSL B+), and the T. Rowe Price International Equity ETF (TOUS A-) all hit that important three-year milestone last month. “Crossing the three-year mark across {the} four ETFs that I’m the lead PM on is definitely a meaningful milestone,” she said. “It moves us out of the new product bucket and into the universe where allocators and clients can judge us on real world decisions through multiple market environments.” “It opens a lot more doors, a lot more platforms, models and databases that require three-year track records,” she added. “So it really does expand the opportunity set for where these funds can live in client portfolios. It does not change how we run them day to day.” See more: What Rising Structural Inflation Means for Your Bond Portfolio The group of funds have all performed well over the last one- and three-year periods. Their performances have been led by TMSL, which has returned 31.8% over the last 12-month period, according to ETF Database data.Consistent Strategies & Evolving Use CasesAsked about how the funds’ approaches may have changed since their launch, Love explained that her process remains focused on fundamentals. The team has learned, however, about the ways in which the funds can be used. “What I would say has evolved is our understanding of the use cases at the margin. Advisors are using these funds both as core building blocks, but also as precise tilts,” she said. She pointed to TMSL as a dedicated SMID sleeve for some. Some use it as a tool to balance away from megacap concentration without taking a big factor bet, as well.  “On the broader franchise scale, we expect the ETFs to slot into more strategic model portfolios,” she explained. “That has definitely happened, but we feel that this milestone will accelerate that and we’re also seeing some more tactical usage.” See more: T. Rowe Price’s Farris Shuggi Talks Fundamental, Quant InvestingSpotlight on the T. Rowe Price Small-Mid Cap ETF (TMSL)TMSL receives the most attention from clients right now, she said. She explained that, having spent most of her career in the SMID-cap space, she believes it’s a category where active management can thrive.  “TMSL is designed as a core SMID building block: diversified, bottom up, with clear but controlled tilts towards quality and sensible valuation,” she said. “So it’s a very intuitive entry point for most portfolios.” “Improving SMID fundamentals…plays directly into what {TMSL} is built to do, which is to find underfollowed businesses where we think we have an edge, where earnings power over the next three to five years is underappreciated,” she added. Looking ahead, TMSL, as well as TVAL, TGRT, and TOUS may now benefit from those three-year track records. The firm, Love said, will continue to rely on its fundamental research. She emphasized that active ETFs are more than just mutual funds in disguise, but “genuinely active research-driven portfolios with intentional tilts.” For more news, information, and analysis, visit our Active ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.